Your browser is no longer supported. Please, upgrade your browser.
Settings
AGN Allergan plc daily Stock Chart
AGN [NYSE]
Allergan plc
IndexS&P 500 P/E- EPS (ttm)-12.52 Insider Own0.20% Shs Outstand340.57M Perf Week-0.68%
Market Cap62.82B Forward P/E11.00 EPS next Y16.78 Insider Trans-9.94% Shs Float338.55M Perf Month5.01%
Income-4187.20M PEG- EPS next Q3.98 Inst Own88.40% Short Float1.08% Perf Quarter20.71%
Sales16.16B P/S3.89 EPS this Y-543.10% Inst Trans0.35% Short Ratio1.75 Perf Half Y16.22%
Book/sh210.10 P/B0.88 EPS next Y2.96% ROA-1.60% Target Price208.45 Perf Year-20.71%
Cash/sh4.98 P/C37.04 EPS next 5Y5.79% ROE-2.60% 52W Range142.81 - 237.41 Perf YTD12.76%
Dividend2.88 P/FCF11.95 EPS past 5Y9.51% ROI-2.10% 52W High-22.30% Beta1.20
Dividend %1.56% Quick Ratio0.80 Sales past 5Y21.90% Gross Margin86.60% 52W Low29.16% ATR3.06
Employees17800 Current Ratio1.00 Sales Q/Q2.90% Oper. Margin-19.10% RSI (14)63.65 Volatility1.34% 1.75%
OptionableYes Debt/Eq0.36 EPS Q/Q40.70% Profit Margin-11.00% Rel Volume0.73 Prev Close184.27
ShortableYes LT Debt/Eq0.34 EarningsJul 26 BMO Payout- Avg Volume2.09M Price184.46
Recom2.10 SMA202.29% SMA505.93% SMA2009.88% Volume1,531,540 Change0.10%
Apr-24-18Resumed Citigroup Buy $200
Apr-23-18Resumed Evercore ISI Outperform
Apr-17-18Initiated Stifel Hold $192
Feb-23-18Initiated SunTrust Buy $200
Feb-07-18Reiterated Leerink Partners Outperform $237 → $242
Dec-07-17Downgrade Argus Buy → Hold
Nov-29-17Upgrade Morgan Stanley Equal-Weight → Overweight
Nov-27-17Resumed Leerink Partners Outperform $237
Nov-02-17Reiterated RBC Capital Mkts Outperform $250 → $221
Oct-19-17Reiterated RBC Capital Mkts Outperform $277 → $250
Oct-17-17Reiterated UBS Buy $275 → $255
Oct-02-17Reiterated Barclays Equal Weight
Sep-25-17Reiterated RBC Capital Mkts Outperform $285 → $277
Sep-20-17Downgrade Morgan Stanley Overweight → Equal-Weight
Jun-16-17Initiated Cantor Fitzgerald Neutral $231
Jun-09-17Reiterated Mizuho Buy $275 → $267
May-10-17Reiterated RBC Capital Mkts Outperform $279 → $284
May-10-17Downgrade Goldman Buy → Neutral
Feb-09-17Reiterated Mizuho Buy $273 → $275
Dec-09-16Reiterated Credit Suisse Outperform $301 → $274
Aug-14-18 11:05AM  Ironwood Rides on Linzess' Progress, Stalls Lenisurad Drugs Zacks
11:02AM  Allergan's (AGN) Stock Up 4.2% Since Q2 Earnings: Here's Why Zacks
Aug-13-18 07:38AM  The Zacks Analyst Blog Highlights: Novo Nordisk, J&J, Allergan, Editas, AstraZeneca, Merck and Bristol-Myers Zacks
Aug-10-18 08:52AM  Pharma Stock Roundup: NVO Q2 Earnings, JNJ, AGN & AZN's Pipeline Updates in Focus Zacks
Aug-09-18 04:17PM  Editas Prepares for the Commercialization of EDIT-101 Motley Fool
Aug-08-18 01:14PM  Editas Medicine (EDIT) Q2 2018 Earnings Conference Call Transcript Motley Fool
08:03AM  Allergan Appoints Neurobiology Expert Michael E. Greenberg, PhD to its Board of Directors as Part of Active Board Refreshment Process PR Newswire
Aug-07-18 10:24AM  Ironwood (IRWD) Q2 Earnings & Revenues Miss, Shares Down Zacks
Aug-06-18 04:01PM  Allergan and Editas Medicine Announce Exercise of Options to Jointly Develop CRISPR Genome Editing Experimental Medicine EDIT-101 PR Newswire
Aug-03-18 11:22AM  Teva (TEVA) Q2 Earnings Beat, Revenues Miss, Stock Down Zacks
04:19AM  Spain's Almirall bets on dermatology with $650 mln U.S. deal Reuters
02:56AM  Spain's Almirall to buy U.S. dermatology portfolio from Allergan Reuters
Aug-02-18 07:42PM  Allergan sues Pfizer over costs of opioid litigation Reuters
04:48PM  Allergan sues Pfizer over costs of opioid litigation Reuters
04:16PM  Allergan sues Pfizer over costs of opioid litigation Reuters
02:31PM  Allergan Sues Pfizer Over Damages in Opioid Litigation Bloomberg
01:13PM  Allergan Sues Pfizer, King Over Opioid Litigation Costs Bloomberg
Jul-31-18 08:20AM  Today's Research Reports on Trending Tickers: Bristol-Myers Squibb and Allergan ACCESSWIRE
06:21AM  Earnings, Tariffs and Video Games in the Blitz CNBC
Jul-30-18 07:02PM  Cramer's lightning round: Buy into Allergan's roaring sto... CNBC Videos
06:50PM  Cramer's lightning round: Buy into Allergan's roaring stock below $180 CNBC
01:39PM  The Blitz: Earnings movers, plus a gaming stock under pre... CNBC Videos
08:00AM  Allergan Announces Third Quarter 2018 Cash Dividend of $0.72 Per Ordinary Share PR Newswire
Jul-27-18 11:43AM  Pharma Stock Roundup: LLY, AGN Post Solid Q2 Results, ABBV's Elagolix Gets FDA Nod Zacks
09:34AM  Dr. Reddy's (RDY) Earnings and Revenues Improve Y/Y in Q1 Zacks
09:14AM  Edited Transcript of AGN earnings conference call or presentation 26-Jul-18 12:30pm GMT Thomson Reuters StreetEvents
02:45AM  Pharma Favorites: 7 Healthy Picks in the Drug Sector Investopedia
Jul-26-18 08:00PM  Allergan Pushes Back on M&A Questions; Comcast Happy With Its Portfolio - ICYMI TheStreet.com
02:06PM  Allergan Announces $2 Billion Share Buyback Program, Raises Guidance TheStreet.com
01:23PM  MARKETS: Facebook aside, earnings are rolling in positive and boosting stocks Yahoo Finance Video
12:23PM  Allergan lifts earnings target, says no drug price hikes this year Reuters
12:10PM  Allergan lifts earnings target, says no drug price hikes this year Reuters
11:30AM  Allergan (AGN) Beats on Q2 Earnings, Unveils Buyback Plan Zacks
08:24AM  Allergan (AGN) Beats on Q2 Earnings and Sales, Stock Up Zacks
07:27AM  [$$] Allergan posts upbeat earnings, unveils $2bn share buyback Financial Times
07:00AM  FOCUS-Amgen's new migraine drug hits insurance hurdles Reuters
06:51AM  Allergan's stock set to rally after earnings beat and raise, new stock repurchase program MarketWatch
06:49AM  Allergan: 2Q Earnings Snapshot Associated Press
06:37AM  Botox-maker Allergan posts smaller quarterly loss Reuters
06:30AM  Allergan Reports Strong Second Quarter 2018 Results Including GAAP Net Revenues of $4.1 Billion PR Newswire
05:08AM  Nasdaq set to drop after Facebook earnings, Dow poised for rise CNBC
01:00AM  FOCUS-Amgen's new migraine drug hits insurance hurdles Reuters
Jul-25-18 02:30PM  Allergan's Q2 Earnings Preview Benzinga
10:27AM  Drug Stocks to Report Earnings on Jul 26: AMGN, ALXN & More Zacks
Jul-24-18 11:57AM  Allergan's Depression Candidate Gets Fast Track Designation Zacks
Jul-23-18 11:03AM  Allergan (AGN) to Report Q2 Earnings: What's in the Cards? Zacks
07:30AM  Wired News Allergan and Molecular Partners Abicipar Meets Primary Endpoint in SEQUOIA and CEDAR Trials ACCESSWIRE
Jul-20-18 04:20PM  U.S. court rejects Allergan bid to shield patents through tribe deal Reuters
11:12AM  Court Says Allergan Can't Shield Restasis Patents With Tribe Bloomberg
Jul-19-18 01:32PM  Final Trades: Honeywell, Allergan, Under Armour and Cabot... CNBC Videos
09:50AM  AGN or TLGT: Which Is the Better Value Stock Right Now? Zacks
09:45AM  AGN vs. TLGT: Which Stock Should Value Investors Buy Now? Zacks
09:02AM  Allergan, Molecular Partners eye drug meets main goal in two studies Reuters
08:26AM  Allergan, Molecular Partners eye drug meets main goal in two studies Reuters
08:00AM  Allergan and Molecular Partners Announce Two Positive Phase 3 Clinical Trials for Abicipar pegol 8 and 12-week Regimens for the Treatment in Patients with Neovascular Age-Related Macular Degeneration PR Newswire
Jul-13-18 10:36AM  Aurinia Pharmaceuticals Has Lots of Upside Potential InvestorPlace
Jul-11-18 06:59AM  Examining Allergan: Cramer Goes 'Off the Charts' TheStreet.com
Jul-10-18 07:38PM  Don't get too excited about Botox maker Allergan CNBC Videos
06:59PM  Cramer Remix: This hidden stock has great long-term prospectsbut theres a catch CNBC
06:43PM  Cramer: Don't get your hopes up with the stock of Botox m... CNBC Videos
06:33PM  Cramer: Don't get your hopes up with the stock of Botox maker Allergan CNBC
11:58AM  Top Analyst Reports for Union Pacific, 21st Century Fox & BP Zacks
11:54AM  Trump Tweets Threat to Pfizer but Investors Shrug it Off InvestorPlace
08:00AM  Allergan Expands REFRESH® Portfolio With New REFRESH® REPAIR Lubricant Eye Drops PR Newswire
Jul-09-18 04:25PM  This Blockbuster Drug Could Help Allergan Boost Its 2018 Numbers Investor's Business Daily
12:03PM  Allergan Stock Is Worth a Look for Long-Term Investors InvestorPlace
Jul-06-18 10:56AM  5 Pharmaceutical and Biotech Stocks to Consider for July InvestorPlace
06:00AM  5 Bargain Biotechs Poised for Big Short-Term Gains Investopedia
Jul-03-18 08:41AM  Adamis (ADMP) Surges Following Novartis Deal for Symjepi Zacks
08:39AM  The Zacks Analyst Blog Highlights: Bank of America, Wells Fargo, Honeywell, Allergan and Enterprise Products Zacks
Jul-02-18 12:01PM  Top Research Reports for Bank of America, Wells Fargo & Honeywell Zacks
09:30AM  Is Allergan (AGN) a Suitable Stock for Value Investors Now? Zacks
09:30AM  Has Allergan plc (AGN) Outpaced Other Medical Stocks This Year? Zacks
09:30AM  AGN vs. AMPH: Which Stock Is the Better Value Option? Zacks
Jun-28-18 09:00AM  Allergan Eases Manual Data Entry and Contract Management Pains with Pramatas Billing Accuracy Solution GlobeNewswire
08:01AM  Allergan's Study in Chronic Migraine Receives Migraine Research Award at the American Headache Society's 60th Annual Scientific Meeting PR Newswire
07:00AM  Healthcare: Drug Pricing Concerns Weigh on Valuations, Creating Opportunities Morningstar
Jun-27-18 07:00AM  Stock Market Outlook: Some Values to Be Found in Defensive Sectors Morningstar
Jun-26-18 08:00AM  Allergan to Report Second Quarter 2018 Earnings and Host Conference Call and Webcast PR Newswire
Jun-25-18 02:54PM  Allergan plcs (NYSE:AGN) Shift From Loss To Profit Simply Wall St.
07:10AM  Free Technical Research on Akorn and Three More Generic Drugs Equities ACCESSWIRE
Jun-21-18 05:15PM  Allergan Promotes Male Botox Users With Big Campaign Bloomberg Video
05:15PM  Allergan Promotes Male Botox Users With Big Campaign Bloomberg
05:00AM  Wanted: Wrinkled Men Not Afraid of Needles for Brotox Revival Bloomberg
Jun-20-18 01:36PM  Boston Scientific, Masco, MasterCard, Allergan & Paypal CNBC Videos
Jun-15-18 09:32AM  Teva Pharmaceutical Industries Limited Stock Still Is a Deep Value Play InvestorPlace
09:27AM  Pharma Stock Roundup: LLY/AZN Alzheimer's Drug Fails, MRK's Keytruda Wins Approvals Zacks
Jun-14-18 05:05PM  Is Goldman Sachs Going to Be the Next Allergan? TheStreet.com
11:31AM  Allergan (AGN) Presents Positive Data on Glaucoma Candidate Zacks
08:28AM  Allergan appoints former Abbott executive to its board Reuters
08:25AM  Detailed Research: Economic Perspectives on Stein Mart, Asbury Automotive Group, Sprint, The Kraft Heinz, Allergan plc, and Fitbit What Drives Growth in Today's Competitive Landscape GlobeNewswire
08:00AM  Allergan Continues Active Board Refreshment Process PR Newswire
Jun-13-18 08:00AM  Allergan Announces Positive Topline Phase 3 Clinical Data for Bimatoprost SR (Sustained-Release) Implant for IOP Lowering in Patients with Open-Angle Glaucoma or Ocular Hypertension PR Newswire
Jun-12-18 10:14AM  Allergan's Second Anti-CGRP Drug Positive in Mid-Stage Study Zacks
Jun-11-18 09:14AM  Allergan oral migraine drug succeeds in study Reuters
09:04AM  What to Do After Axovant Sciences Ltd Skyrockets Three-fold in a Month InvestorPlace
08:00AM  Allergan's Oral CGRP Receptor Antagonist Atogepant Demonstrates Robust Efficacy and Safety in Episodic Migraine Prevention in a Phase 2b/3 Clinical Trial PR Newswire
Jun-08-18 10:27AM  Pharma Stock Roundup: MRK Impresses at ASCO, LLY Gets FDA Nod for Olumiant Zacks
09:45AM  Bernstein: What Activism Means For Allergan Shareholders Benzinga
Jun-07-18 10:43PM  Asian shares fall ahead of G7 summit, central bank meetings Associated Press +5.08%
Allergan plc, a specialty pharmaceutical company, develops, manufactures, markets, and distributes medical aesthetics, biosimilar, and over-the-counter pharmaceutical products worldwide. It operates through US Specialized Therapeutics, US General Medicine, and International segments. The company offers a portfolio of products that provide treatment for the central nervous system, gastroenterology, women's health and urology, ophthalmology, neurosciences, medical aesthetics, dermatology, plastic surgery, liver disease, inflammation, metabolic syndromes, and fibrosis, as well as Alzheimer's disease. It is also involved in developing ocular implants that reduce intraocular pressure associated with glaucoma; medical devices for the correction of prominent ears; and intranasal neurostimulation devices, as well as other dry eye products. In addition, the company distributes generic and branded pharmaceutical products primarily to independent and chain pharmacies, nursing homes, mail order pharmacies, hospitals, clinics, and physician offices. Further, it develops a portfolio of breast implants and tissue expanders; and RM-131 (relamorelin), a peptide ghrelin agonist for the treatment of diabetic gastroparesis. The company has licensing agreement with Assembly Biosciences, Inc.; Mimetogen Pharmaceuticals, Inc.; Almirall, S.A; Naurex, Inc.; and Merck & Co. The company was formerly known as Actavis plc and changed its name to Allergan plc in June 2015. Allergan plc was founded in 1983 and is headquartered in Dublin, Ireland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Basgoz NesliDirectorAug 10Option Exercise81.161,889153,3119,248Aug 14 05:32 PM
Meury WilliamEVP & Chief Commercial OfficerMay 17Option Exercise68.1121,2521,447,47440,154May 21 05:21 PM
Meury WilliamEVP & Chief Commercial OfficerMay 17Sale154.5924,4253,775,86115,729May 21 05:21 PM
Hilado Maria TeresaExecutive Vice PresidentMar 15Buy167.39895149,81426,530Mar 19 09:36 AM
WALSH MATTHEW MEVP, Chief Financial OfficerMar 08Buy153.961,000153,96025,416Mar 08 10:44 AM
SAUNDERS BRENT LChairman, President and CEOMar 08Buy152.533,300503,349180,931Mar 08 10:25 AM
Boccuzi Joseph HDirectorMar 05Buy143.42900129,0781,862Mar 09 04:31 PM
WALSH MATTHEW MEVP, Chief Financial OfficerFeb 21Buy160.942,000321,88024,416Feb 22 04:25 PM
Meury WilliamChief Commercial OfficerFeb 14Option Exercise63.1723,6131,491,73778,600Feb 16 05:10 PM
Meury WilliamChief Commercial OfficerFeb 14Sale160.6258,8799,457,36919,721Feb 16 05:10 PM
BODINE CHRIS WDirectorDec 07Buy164.773,030499,25317,098Dec 07 05:21 PM
SAUNDERS BRENT LChairman, President and CEODec 06Buy164.744,600757,794186,377Dec 06 12:31 PM
COUGHLIN CHRISTOPHER JDirectorDec 05Buy163.3010,0001,633,00014,446Dec 05 04:16 PM
Meury WilliamChief Commercial OfficerDec 01Option Exercise78.8811,807931,33668,828Dec 04 06:21 PM
Meury WilliamChief Commercial OfficerDec 01Sale173.8911,8072,053,11957,021Dec 04 06:21 PM